HOUSTON, April 22,
2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex
Health" or the "Company") (NASDAQ: NUTX), a physician-led,
technology-enabled integrated healthcare delivery system comprised
of 21 state-of-the-art micro hospitals in 9 states and primary
care-centric, risk-bearing physician networks, today announced the
appointment of Scott J. Saunders,
and Kelvin Spears, MD, to its Board
of Directors. They replace John
Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term
Board commitment.
The Board has determined that Mr. Saunders satisfies the current
independent director standards established by the rules of The
Nasdaq Stock Market. Mr. Saunders will serve as a Director of the
Company for a term commencing on April 11,
2024, and expiring at the Annual Meeting of Stockholders of
the Company in 2025 or until his successor is duly elected and
qualifies.
Mr. Saunders is head of health care advisory services and has
been a Managing Director of Farlie Turner
Gilbert & Co., LLC, a boutique middle market investment
bank based in Fort Lauderdale,
Florida, since 2006. Since 1992, he has served as a
financial and strategic advisor to middle market companies across a
variety of industries, including companies primarily in the
healthcare industry.
In addition, he has advised companies in the media and
communications, business services, industrial, and consumer
products industries. The majority of transactions consummated
during this period have been corporate divestitures but have also
included debt and equity private placements and buy-side advisory
work.
Mr. Saunders has been a guest lecturer at the University of Miami and Florida International University. In addition, he
co-taught a class in management consulting to undergraduates and
graduate students in the Management Department at the University of Miami. He is a frequent panelist at
industry conferences on topics in healthcare M&A and financing.
Throughout his career, he has developed relationships with key
representatives of leading middle market private equity and private
credit firms, as well as mezzanine capital firms, BDCs, and
selected hedge funds.
Mr. Saunders received his B.A. degree from Wesleyan University and his MPPM degree from the
Yale University School of
Management. The Company believes that Mr. Saunders's
background and experience in healthcare advisory roles make him
well qualified to serve as a Director.
Dr. Spears completed his emergency medicine residency followed
by a fellowship in Critical Care at Martin Luther King Jr., Charles
Richard Drew University Health
Sciences, in Los Angeles,
California. Prior to his residency, he earned his medical
degree from Meharry Medical College.
Prior to this, he received a B.S. in Chemistry from Dillard University.
Dr. Spears is board certified in Emergency Medicine by the
American Board of Emergency Medicine and is a Fellow of the
American College of Emergency Physicians. Dr. Spears has been a
practicing emergency medicine physician for over 32 years.
Since 2017, Dr. Spears has been a Physician Partner, Chief
Medical Director, and ED Director at Alexandria Emergency Hospital in Alexandria, LA, a hospital affiliate of the
Company. Dr. Spears also serves as the EMS Medical Director for
Alexandria Fire Department,
Pineville Fire Department, Cotile
Fire Department, Central Louisiana Bureau EMS, Kisatchie Forest/US
Forest Service and Rapides Parish School.
Additionally, from 2014 to 2017 he served as Emergency
Department Director at Christus St. Frances Cabrini Hospital in
Alexandria, Louisiana, Contract
Management Group SMD, Envision Healthcare, and Sound Physicians,
servicing a 45,000 patient per year Emergency Department. Dr.
Spears' dedication to providing quality healthcare in the most
efficient and effective methods, along with his extensive EMS
background and wealth of experience, make him well-qualified to
serve as a director.
"We are extremely excited about having both Scott Saunders and Dr. Kelvin Spears on our Board. Each brings a unique
set of skills that will add value to our corporate governance,"
said Tom Vo, M.D., MBA, Chief
Executive Officer and Chairman of Nutex Health.
"I'm looking forward to contributing to Nutex Health's
Board. While the Company has encountered some headwinds in
the past two years, I believe its recently-adopted cost-cutting
initiatives will position it well for long term profitability and
growth," said Mr. Saunders.
"I believe micro hospitals and the kind of value-based care
represented by Nutex Health's primary care networks are important
ingredients in the future of healthcare. Nutex Health is a
leader in this micro hospital sector and I'm glad to be a part of
the Company," said Dr. Spears.
About Nutex Health Inc.
Headquartered in Houston, Texas
and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a
physician-led, technology-enabled integrated healthcare delivery
system comprised of 21 state-of-the-art micro hospitals in nine
states and primary care-centric, risk-bearing physician networks
with two divisions: a Hospital Division and a Population Health
Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 21 facilities in nine states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). Through our Management Services Organization (MSO), we
provide management, administrative and other support services to
our affiliated hospitals and physician groups. Our cloud-based
proprietary technology platform aggregates clinical and claims data
across multiple settings, information systems and sources to create
a holistic view of patients and providers, allowing us to deliver
greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," "goal," or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include, but are not limited to, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including the interim final and final rules
implemented under the No Surprises Act, economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in our Annual Report on Form 10-K for the
year ended December 31, 2023 under
the heading "Risk Factors" in Part I, Item IA thereof, and other
documents filed from time to time with the Securities and Exchange
Commission. Such factors could materially adversely affect the
Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-announces-changes-to-its-board-of-directors-302122945.html
SOURCE Nutex Health, Inc.